2-[3,5-dimethyl-4-(1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyrazol-1-yl]-1-phenylethanone | 1029046-55-6

• 英文名称: 2-[3,5-dimethyl-4-(1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyrazol-1-yl]-1-phenylethanone
• 英文别名: 2-[3,5-dimethyl-4-(1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)pyrazol-1-yl]-1-phenylethanone
• CAS: 1029046-55-6
• 化学式: C₂₁H₂₀N₄O
• 分子量: 344.416
• InChiKey: JAPKNEPEIJCQPP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Compounds modulating c-fms and/or c-kit activity and uses therefor
  申请人：Zhang Jiazhong

  公开号：US20090076046A1

  公开（公告）日：2009-03-19

  Compounds active on the receptor protein tyrosine kinases c-kit and/or c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or conditions and/or c-fms-mediated diseases or conditions, and methods for the use thereof.

  提供了对受体蛋白酪氨酸激酶c-kit和/或c-fms活性的化合物。还提供了用于治疗c-kit介导的疾病或病状和/或c-fms介导的疾病或病状的组合物，以及使用它们的方法。
• COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY
  申请人：Zhang Jiazhong

  公开号：US20110230482A1

  公开（公告）日：2011-09-22

  Compounds active on the receptor protein tyrosine kinases c-kit and/or c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or conditions and/or c-fms-mediated diseases or conditions, and methods for the use thereof.

  本文提供了对受体蛋白酪氨酸激酶c-kit和/或c-fms活性化合物。还提供了用于治疗c-kit介导的疾病或状况和/或c-fms介导的疾病或状况的组合物，以及其使用方法。
• COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR
  申请人：Zhang Jiazhong

  公开号：US20120309756A1

  公开（公告）日：2012-12-06

  Compounds active on the receptor protein tyrosine kinases c-kit and/or c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or conditions and/or c-fms-mediated diseases or conditions, and methods for the use thereof.

  本文提供了在受体蛋白酪氨酸激酶c-kit和/或c-fms上活性化合物。还提供了用于治疗c-kit介导的疾病或状况和/或c-fms介导的疾病或状况的组合物，并提供了其使用方法。
• KINASE MODULATION AND INDICATIONS THEREFOR
  申请人：PLEXXIKON INC.

  公开号：US20130274259A1

  公开（公告）日：2013-10-17

  Compounds, compositions and methods useful for treatment of Flt3-mediated diseases or conditions are provided herewith. Also provided herewith are methods for modulating the receptor protein tyrosine like kinase 3(Flt3).
• US7893075B2
  申请人：——

  公开号：US7893075B2

  公开（公告）日：2011-02-22